Gossamer Bio Announces Inducement Grant Under Nasdaq Listing

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary...

Related Keywords

, Nasdaq , Gossamer Bio Inc , Compensation Committee Of Gossamer Board Directors , Gossamer Bio , Compensation Committee , Inducement Incentive Award Plan , Nasdaq Listing Rule , Nasdaq Global Select Market ,